1 SOLAR, EVS AND A BIG EXIT FROM COAL: 2024’S GOOD CLIMATE NEWS WWW.BLOOMBERG.COM PUBLISHED:2024/12/25      2 OVER 636,000 MONGOLIANS USE THE WHAT3WORDS APPLICATION WWW.MONTSAME.MN PUBLISHED:2024/12/25      3 CHINA EXPRESSES READINESS TO RESOLVE GASHUUNSUKHAIT-GANTSMOD CROSS-BORDER RAILWAY PROJECT ISSUES WWW.MONTSAME.MN PUBLISHED:2024/12/25      4 BOGD BANK AND FMO BEGIN COOPERATION TO SUPPORT SMES AND GREEN PROJECTS IN MONGOLIA WWW.MONTSAME.MN PUBLISHED:2024/12/25      5 THE BANK OF MONGOLIA: LEGAL REFORMS NEEDED TO ENSURE CENTRAL BANK INDEPENDENCE WWW.GOGO.MN PUBLISHED:2024/12/25      6 SNOW COVERS OVER 60 PCT OF MONGOLIAN TERRITORY WWW.XINHUANET.COM PUBLISHED:2024/12/24      7 DIGITAL TRANSFORMATION AND DEVELOPMENT OF ARTIFICIAL INTELLIGENCE DISCUSSED WWW.MONTSAME.MN PUBLISHED:2024/12/24      8 MONGOLIAN AND JAPANESE AIRPORTS TO EXCHANGE BEST PRACTICES AND ENHANCE SERVICE QUALITY WWW.MONTSAME.MN PUBLISHED:2024/12/24      9 MONGOLIA'S SOVEREIGN WEALTH FUND RENAMED “CHINGGIS FUND” WWW.MONTSAME.MN PUBLISHED:2024/12/24      10 DEFENSE MINISTRY OF MONGOLIA TO SUPPLY MEAT TO VIETNAMESE ARMY WWW.AKIPRESS.COM PUBLISHED:2024/12/24      ЭХЯ: ДЦС-3-ЫГ 300 МВТ-ААР ӨРГӨТГӨХ ТӨСЛИЙН ӨРТӨГ 1.3 ТЭРБУМ ЕВРО БАЙНА WWW.BLOOMBERGTV.MN НИЙТЭЛСЭН:2024/12/25     НҮҮРСНИЙ ЭКСПОРТЫГ 100 САЯ ТОННД ХҮРГЭХ ЗАМЫГ ЗАСАХ ГАШУУНСУХАЙТ-ГАНЦМОДЫН ХЭЛЭЛЦЭЭРИЙН ЭРГЭН ТОЙРОНД... WWW.BLOOMBERGTV.MN НИЙТЭЛСЭН:2024/12/25     ХЭРЭГЛЭЭНИЙ БАРАА, ҮЙЛЧИЛГЭЭНИЙ ҮНЭ 8.1 ХУВИАР НЭМЭГДЖЭЭ WWW.EAGLE.MN НИЙТЭЛСЭН:2024/12/25     ЗГ: "ОРАНО МАЙНИНГ" ХХК ЭХНИЙ САНХҮҮЖИЛТЭЭР 500 САЯ ДОЛЛАРЫГ ГАРГАНА WWW.NEWS.MN НИЙТЭЛСЭН:2024/12/25     ОРОН СУУЦНЫ ҮНЭ 13 ХУВИАР НЭМЭГДЖЭЭ WWW.MONTSAME.MN НИЙТЭЛСЭН:2024/12/25     МОНГОЛБАНКНЫ ҮНЭТ ЦААСНЫ ҮЛДЭГДЭЛ ₮10.7 ИХ НАЯД БОЛЖ, ӨМНӨХ ОНЫ МӨН ҮЕЭС 21 ХУВИАР ӨСӨВ WWW.BLOOMBERGTV.MN НИЙТЭЛСЭН:2024/12/24     БНХАУ-ЫН ЗАСГИЙН ГАЗАР ГАШУУНСУХАЙТ-ГАНЦМОД БООМТЫН ТӨСЛИЙГ ОЛОН УЛСЫН ГЭРЭЭГЭЭР ШИЙДВЭРЛЭХЭД БЭЛЭН ГЭДГЭЭ ИЛЭРХИЙЛЛЭЭ WWW.EAGLE.MN НИЙТЭЛСЭН:2024/12/24     НҮҮРСНИЙ ЭКСПОРТ 78.5 САЯ ТОННД ХҮРЭВ WWW.MONTSAME.MN НИЙТЭЛСЭН:2024/12/24     "НЭГ УУТ БЭЛЭГ 36-72 ШИРХЭГ ЁОТОНТОЙ ТЭНЦЭХ САХАР АГУУЛДАГ" WWW.NEWS.MN НИЙТЭЛСЭН:2024/12/24     НЭМЭЛТЭЭР ДАХИН ЗУРГААН ЧИГЛЭЛД ТУСГАЙ АВТОБУС ГАРГАНА WWW.MONTSAME.MN НИЙТЭЛСЭН:2024/12/24    

Australian court increases fine over 'misleading' Nurofen www.bbc.com

The UK manufacturer of Nurofen has been hit with an increased fine of A$6m (£3.6m; $4.4m) for misleading customers in Australia.
Australia's Federal Court ruled last year that products marketed as targeting specific pains, such as migraines, were actually identical.
Reckitt Benckiser was fined A$1.7m in April, but Australia's consumer watchdog argued the sum was too low.
The court on Friday agreed to increase the penalty.
"The objective of any penalty in this case must be to ensure that Reckitt Benckiser and other 'would-be wrongdoers' think twice and decide not to act against the strong public interest," the court's justices said in a joint statement.
The pharmaceutical giant was also ordered to pay the Australian Competition and Consumer Commission's (ACCC) legal costs.
The ACCC said the company had profited substantially from misleading customers on products including Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache.
"This is the highest corporate penalty awarded for misleading conduct under the Australian Consumer Law," ACCC Chairman Rod Sims said.

"The ACCC welcomes this decision, having originally submitted that a penalty of $6 million or higher was appropriate given the longstanding and widespread nature of the conduct, and the substantial sales and profit that was made."
In a statement to the BBC, Nurofen said it acknowledged the court's decision but would seek legal advice.
"Nurofen is disappointed by this decision, as it considers that the original penalty of the Federal Court in April was appropriate in all of the circumstances," the statement read.
The court in April ruled that Reckitt Benckiser had contravened Australian consumer law by saying its Nurofen Specific Pain products were each formulated to treat a specific type of pain.
Each product contained the same active ingredient, ibuprofen lysine 342mg.
The company said: "Nurofen did not intend to mislead consumers, however we recognise that we could have done more to assist our consumers in navigating the Nurofen Specific Pain Range."
Earlier this year, Reckitt Benckiser removed a TV advert for one of its products - Nurofen Express. The advert had implied that the capsules directly targeted muscles in the head.
The company has said it will not re-broadcast it, following complaints that the ad was misleading.

 
 
 


Published Date:2016-12-16